healthcare.digital September 23, 2025
Executive Summary
This report provides a definitive analysis for venture capital (VC) investment in the value-based care (VBC) healthtech sector. While VBC represents a profound and necessary paradigm shift with a multi-trillion-dollar market opportunity, it is not an environment for unsophisticated capital. The core finding is a qualified “yes”: venture capital should strategically back VBC healthtech, but only by targeting specific business models and deploying patient capital with a deep understanding of the unique operational, regulatory, and financial risks.
The market is propelled by a macroeconomic imperative to curb escalating costs and is strongly incentivised by top-down regulatory mandates from entities like CMS. However, startups face structural hurdles, including fragmented data ecosystems, notoriously long sales cycles, and resistance from entrenched...







